Europe Benign Prostatic Hyperplasia Market and Competitive Landscape Highlights 2015-2020 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Europe Benign Prostatic Hyperplasia Market and Competitive Landscape Highlights - 2016" drug pipelines to their offering.

Europe Benign Prostatic Hyperplasia Market and Competitive Landscape Highlights - 2016, provides comprehensive insights into Benign Prostatic Hyperplasia pipeline products, Benign Prostatic Hyperplasia epidemiology, Benign Prostatic Hyperplasia market valuations and forecast, Benign Prostatic Hyperplasia products sales and competitive landscape.

This report is classified into nine sections - Benign Prostatic Hyperplasia overview including etiology, pathophysiology, and diagnosis, Benign Prostatic Hyperplasia treatment options, Benign Prostatic Hyperplasia pipeline products, Benign Prostatic Hyperplasia market analysis in Europe and by each country.

The market analysis comprises of Benign Prostatic Hyperplasia epidemiology, key products marketed for Benign Prostatic Hyperplasia, market valuations and forecast, products sales and market shares.

Research Scope:

  • Pipeline: Find out the products in clinical trials for the treatment of Benign Prostatic Hyperplasia by development phase 3, phase 2, and phase 1, by pharmacological class and companies developing the products
  • Epidemiology: Find out the number of patients diagnosed (prevalence) with Benign Prostatic Hyperplasia
  • Products: Identify key products marketed and prescribed for Benign Prostatic Hyperplasia including trade name, molecule name, and company
  • Product Sales: Find out the sales revenues of Benign Prostatic Hyperplasia products, both branded and generics
  • Market Valuations: Find out the market size for Benign Prostatic Hyperplasia products in 2015 for the markets: Find out how the market advanced from 2010 and forecast to 2020
  • Products Market Share: Find out the market shares for key Benign Prostatic Hyperplasia products

Key Topics Covered:

1 Disease Overview

2 Benign Prostatic Hyperplasia Treatments

3 Benign Prostatic Hyperplasia Pipeline

4 Europe Benign Prostatic Hyperplasia Market Insights

5 Germany Benign Prostatic Hyperplasia Market Insights

6 France Benign Prostatic Hyperplasia Market Insights

7 Italy Benign Prostatic Hyperplasia Market Insights

8 Spain Benign Prostatic Hyperplasia Market Insights

9 UK Benign Prostatic Hyperplasia Market Insights

For more information about this drug pipelines visit http://www.researchandmarkets.com/research/js7qmz/europe_benign

Related Topics: Prostate Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716